tert-butyl (S)-3-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indole-1-carboxylate

Catalog No. :
ACGMWY384
CAS No. :
405555-31-9
Molecular Formula :
C32H32N2O6
Molecular Weight :
540.62

IUPAC Name:tert-butyl (S)-3-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indole-1-carboxylate

tert-butyl (S)-3-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indole-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl (S)-3-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indole-1-carboxylate
IUPAC Nametert-butyl (S)-3-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxy-3-oxopropyl)-1H-indole-1-carboxylate
Molecular FormulaC32H32N2O6
Molecular Weight540.62
SMILESCOC(=O)[C@H](CC1=CN(C(=O)OC(C)(C)C)C2=CC=CC=C12)NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21
InChI KeyBEQBLVGYJSGKLW-MHZLTWQESA-N
CAS No.405555-31-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACGMWY384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGMWY384 route product structure diagram
    ACGMWY384405555-31-9
Inquiry

2. ACGMWY384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMEYV583 route compound structure diagram
    ACMEYV58396238-70-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGMWY384 route product structure diagram
    ACGMWY384405555-31-9
Inquiry

Comments (0)